Pulmonary arterial hypertension exacerbated by ruxolitinib
File(s)haematol.2014.120816.full.pdf (509.98 KB)
Accepted version
Author(s)
Low, AT
Howard, L
Harrison, C
Tulloh, RMR
Type
Journal Article
Date Issued
2015-06-01
Date Acceptance
2015-02-14
Citation
Haematologica, 2015, 100 (6), pp.E244-E245
ISSN
0390-6078
Publisher
Ferrata Storti Foundation
Start Page
E244
End Page
E245
Journal / Book Title
Haematologica
Volume
100
Issue
6
Copyright Statement
© Ferrata Storti Foundation
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358577000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Hematology
Drug induced pulmonary arterial hypertension
Ruxolitinib
Myelofibrosis
JAK inhibitor
JAKS
Disease Progression
Female
Humans
Hypertension, Pulmonary
Janus Kinases
Middle Aged
Pyrazoles
Immunology
Cardiovascular Medicine And Haematology
Publication Status
Published